By comparing 20 biomarkers across three human septic panels, we ascertained that ICAM1, IL1B, FAS, and RETN were statistically elevated in the blood of IBD patients, which indicates the existence of a gut injury-induced systemic inflammation pathway. This evidence concerns the gene IL1B and inflammatory bowel disease.